Search Scholars Central
Articles, journals and conferences in one search. An exact title, DOI or ISSN is listed first.
Advanced searchHide advanced search
In the search box: "exact phrase" · -leave out · OR · prefix* · title: author: journal:
Perspective · 20 Feb 2024 Perspective · 26 Dec 2023 Harnessing the Power of Antibodies and Antibody-Drug Conjugates: A Revolution in Targeted Therapies
Review article · 29 Jun 2023 Pharmacokinetics of Antibodies: Understanding the Dynamics of Therapeutic Antibodies in the Body
Antibodies have become essential tools in the field of biomedicine, with an increasing number of therapeutic antibodies being developed for the treatment of various diseases. Understanding the pharmacokinetics of these…
Conference abstract · 1 Jun 2023 Serum levels of antibodies and cross-reactive antibodies against the spike protein variants of SARS-CoV-2 in the vaccinated people and non-vaccinated people who have recovered from natural infection
spike protein of the SARS-CoV-2 is the major site of neutralizing antibodies and also shows robust mutation. Hence, it is crucial to understand the host immune response against ... determining the vaccine efficacy…
Mini review · 30 May 2023 Technology Considerations for production of Antibodies and Antibody-Drug Conjugates in Cancer Therapy
cornerstone for the therapeutic antibody field’s explosive growth and development is the capacity of monoclonal antibodies to bind to a target antigen with high specificity and either neutralise ... boost its activity…
Conference abstract · 29 Mar 2023 Treatment of Anti-Neutrophil Cytoplasmatic Antibody (ANCA)-related vasculitis
ANCA-associated vasculitis is a well-known clinico-pathological group of systemic
Commentary · 30 Dec 2022 Tests for the Antibodies and Process of Isolating and Purifying Antibodies
Case report · 31 Oct 2022 Anti-Phospholipid Antibody Syndrome: Antiphospholipid-Protein Antibodies and Ischemic
Antiphospholipid syndrome is characterized by arterial or venous thrombosis and the presence of antiphospholipid antibodies (APL). We measured β2-GPI aCL, IgGaCL, LA, antiphosphatidyl-serine antibody (PS), and…
Conference abstract · 9 Mar 2022 GEOMETRY OF Ah RECEPTOR’ LIGAND BINDING SITE STUDIED WITH IDIOTYPIC AND ANTI-IDIOTOPIC MONOCLONAL ANTIBODIES TO 2,3,7,8-TCDD.
original approach was developed consisting of the development of monoclonal antibodies (Mab) against the most potent xenobiotic 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD). The TCDD was adducted ... semi-quantitate…
Conference abstract · 24 Jan 2022 FceR1g negative NK-cells (g-nNK) enhance antibody dependent cellular cytotoxicity and in vivo efficacy of therapeutic monoclonal antibodies against hematologic malignancies
Monoclonal antibodies (mAbs) are a central component of therapy for hematologic malignancies. Widely used mAb agents in multiple myeloma (MM) include daratumumab and elotuzumab. However, not all patients respond…
Case report · 27 Oct 2021 Anti-Hu Antibody- and Anti-Zic4 Antibody-Positive Paraneoplastic Neurological Syndrome Presenting with Cerebellar Degeneration and Cranial Neuropathy: A Case Report
central nervous system. Our patient presented high titers of Anti-Hu and anti-Zic4 antibodies in her serum. We review the literature and found that multiple cranial palsies and concurrent
Short communication · 11 Aug 2021 COVID-19 antibody
The first two cases of COVID-19 in Santa Clara County, California
Article · 27 Apr 2021 A Five Years Retrospective Trends of Rubella Virus IgM Antibodies from Measles Suspected Cases with Negative/Intermediate Results for Measles Infection: From 2015-2019
infection. Therefore, this study aimed to assess retrospective trends of rubella virus-specific IgM antibodies from measles suspected cases with negative/intermediate results for measles infection
Mini review · 5 Mar 2021 A Five Years Retrospective Trend of Rubella Virus Igm Antibodies from Measles Suspected Cases with Negative/ Intermediate Results for Measles Infection: from 2015-2019
infection. Therefore, this study aimed to assess retrospective trends of rubella virus-specific IgM antibodies from measles suspected cases with negative/ intermediate results for measles infection. Methods: A…
Conference abstract · 21 Dec 2020 Antibodies with Functionality as a New Generation of Translational Tools designed to secure Upgraded Biodesign and Bioengineering of the Future to come
Abs against myelin basic protein/MBP endowing with proteolytic activity (Ab-proteases
Conference abstract · 25 Oct 2020 ELISAs for determination of ochratoxin A by monoclonal anti-ochratoxin A antibody or F(ab')2 fragment
this study was to develop sensitive ELISAs on the base of mice monoclonal antibody (mAb) against ochratoxin A (OTA) or its F(ab')2 fragment. The mice mAb was produced ... using obtained F(ab')2 fragment and anti-OTA…
Conference abstract · 25 Oct 2020 A Novel Versatile Antibody-Drug Conjugate for Cancer Therapy
Abstract Antibody drug forms (ADCs), a promising cutting edge counter acting agent drug, join tumor particularity with exceptionally powerful cytotoxic payload for improve remedial adequacy in disease treatment…
Short communication · 28 Sep 2020 In utero anti HBV antibodies transmission from mother to fetus
child during pregnancy. In addition, when mothers are immunized, they can transfer their antibodies to their fetus during pregnancy, as a passive immunity. According to this, we evaluated in south ... Cotonou and at Deo…
Conference abstract · 31 Aug 2020 Antibodies with Functionality as a New Generation of Translational Tools designed to be programmed via translational resources to predict and to prevent Demyelination
Abs against myelin basic protein/MBP endowing with proteolytic activity (Ab-proteases
Letter · 20 Jul 2020 Persistent Preformed Donor-Specific Antibodies and Clinical Risks of de novo Donor-Specific Antibody Development after Kidney Transplantation
Methods used to identify alloantibodies have become increasingly more sensitive and specific
Conference abstract · 24 Jun 2020 Adalimumab Antibody Affinity Maturation: an In Silico Approach
therapeutic target for the treatment of RA. Adalimumab is a human monoclonal antibody (IgG1) against TNF-α which has been approved by FDA for the treatment of arthritis and other ... inflammatory related diseases. For a…
Case report · 11 May 2020 Efficacy of Anti-CD Monoclonal Antibody in SLE-Related Sneddonandrsquo;s Syndrome with Anti phospholipid Antibodies and Interstitial Lung Disease: A Case Report
Antiphospholipid Syndrome and related to Systemic Lupus Erythematosus (SLE) with or without anti-phospholipid antibodies. To date, there are very few indications for diagnosis and treatment. Skin biopsy and brain…

